Skip to main content

Table 3 Description of SF-36v2 and HJHS scores upon study entry and exit in 17 male subjects with severe/moderate HA on a LDDP regimen

From: Adherence to treatment regimen and bleeding rates in a prospective cohort of youth and young adults on low-dose daily prophylaxis for severe hemophilia A

 

PCS

MCS

HJHS

Baseline

End of study

Baseline

End of study

Baseline

End of study

Median

49.8

52.5

52.4

51.5

16.0

16.0

Minimum

40.0

40.7

33.6

32.6

0.0

0.0

Maximum

59.2

61.0

63.0

62.2

34.0

38.0

Mean

49.1

51.8

51.0

47.9

14.4

13.9

Standard Deviation

5.66

5.92

7.83

9.45

8.54

8.98

t-test

-1.68

1.75

0.45

P value

0.11

0.10

0.66